COPD AWARENESS SURVEY: DO BELGIAN PULMONARY PHYSICIANS COMPLY WITH THE GOLD GUIDELINES 2010?

Abstract Chronic Obstructive Pulmonary Disease (COPD) is underestimated, underdiagnosed and often undertreated in the general population. A survey of 17 structured questions, delivered to all Belgian pulmonary physicians (PPs) (116 responses), evaluated diagnosis and treatment strategies in accordance with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines 2010 and assessed opinions about the importance of diurnal variation of COPD symptoms. All COPD diagnoses (37% new cases) were spirometry confirmed. Main diagnostic parameters were symptoms (99%), external risk factors (99%), clinical examination (97%), exacerbations (96%) and patient mobility (96%). FEV1 (forced expiratory volume in 1s) (97%) or FEV1/FVC (ratio of FEV1 to forced vital capacity) (93%) were used most to assess diagnosis and severity. The 3 most important therapeutic objectives were symptom relief, preventing exacerbations, and improving quality of life; if these were not reached, the preferred strategy (60% of PPs) was adding another medication. Treatment strategies varied with COPD stage: short-acting β2-agonists (90%) and short-acting anti-cholinergics (59%) were used for GOLD I disease, whereas for higher stages long-acting β2-agonists (36-48%) and long-acting anti-cholinergics (79%) were given with inhaled corticosteroids (21-67%). Symptoms were perceived to vary throughout the day, affecting quality of life (97%) and mobility (89%). In particular, respiratory symptoms were more severe in the morning (51-92%), leading PPs to adapt treatment (69%). This survey demonstrated that management of COPD by PPs in Belgium is generally in line with the GOLD guidelines 2010 and that they perceive morning symptoms as being frequent and having an impact on patient’s life.

[1]  L. Kleinman,et al.  Barriers to adherence to COPD guidelines among primary care providers. , 2012, Respiratory medicine.

[2]  Marc Decramer,et al.  Differential Diagnosis in a Primary Care Population with Presumed Airway Obstruction: A Real-Life Study , 2011, Respiration.

[3]  D. Price,et al.  New horizons in early stage COPD--improving knowledge, detection and treatment. , 2011, Respiratory medicine.

[4]  M. Miravitlles,et al.  Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. , 2011 .

[5]  D. Price,et al.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care. , 2010, Mayo Clinic proceedings.

[6]  M Cazzola,et al.  Symptom variability in patients with severe COPD: a pan-European cross-sectional study , 2010, European Respiratory Journal.

[7]  M. Decramer,et al.  Treatment of COPD: the sooner the better? , 2010, Thorax.

[8]  P. Girodet,et al.  Epidemiology of COPD , 2009, European Respiratory Review.

[9]  T. Welte.  Optimising treatment for COPD – new strategies for combination therapy , 2009, International journal of clinical practice.

[10]  M. Partridge,et al.  Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey , 2009, Current medical research and opinion.

[11]  C. Jenkins,et al.  Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study , 2009, Respiratory research.

[12]  C. Côté,et al.  Primary care of the patient with chronic obstructive pulmonary disease-part 1: frontline prevention and early diagnosis. , 2008, The American journal of medicine.

[13]  M. Joo,et al.  Geographic variation of spirometry use in newly diagnosed COPD. , 2008, Chest.

[14]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[15]  S. Hanneman,et al.  A Pilot Home Study of Temporal Variations of Symptoms in Chronic Obstructive Lung Disease , 2007, Biological research for nursing.

[16]  J. D. de Backer,et al.  Early detection of COPD: a case finding study in general practice. , 2007, Respiratory medicine.

[17]  Michael J. Allison,et al.  COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. , 2007, Chest.

[18]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[19]  K. Rabe.  Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies. , 2006, Proceedings of the American Thoracic Society.

[20]  M. Decramer,et al.  Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study. , 2004, Chest.

[21]  M. Decramer,et al.  Management of COPD according to guidelines. A national survey among Belgian physicians. , 2003, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[22]  D. Postma,et al.  Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. , 1994, Thorax.

[23]  M. Decramer,et al.  Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. , 1992, The European respiratory journal.

[24]  D. Postma,et al.  Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group. , 1991, The American review of respiratory disease.